Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697921 | Clinical Oncology | 2016 | 7 Pages |
Abstract
SpaceOAR hydrogel was inserted with minimal side-effects. Dosimetric benefits were greatest at higher rectal doses (V65 to V82). Late grade 1 gastrointestinal toxicity was significantly lower than that seen in patients treated without hydrogel.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
D. Whalley, G. Hruby, F. Alfieri, A. Kneebone, T. Eade,